EUCOMED: The Appropriateness of Evidence and the Learning Curves for Medical Devices in Europe

Supplement Paper to the Eucomed Position paper on Health Technology Assessment (Siebert et al, 2002) Aiming to Clarify two Important Topics that were already partly Addressed in the First Paper: ...

EMA: PIQ/QRD Pre-Opinion Review of Product Information for Referral Procedures and Article 29 Paediatric Procedures

The purpose of this document is to ensure a consistent and efficient approach to review the quality of English product information of referral procedures, in particular Articles 30 and 31 of ...

Polish Ministry of Health: Regulation of the Polish Minister of Health amending the regulation on application and notification fees concerning medical devices and the amount of application fee for the issuance of a certificate of free sale.

Regulation of the Polish Minister of Health of 13.07.2011 amending the regulation on application and notification fees concerning medical devices and the amount of application fee for the issuance ...

HMA: Questions and Answers on Applications for MA.

Question & Answer on how to change the name of a medicinal product prior to granting a marketing authorisation. ...

HMA: Best Practice Guide on the Assessment Report for Mutual Recognition and Decentralised Procedures.

Art 28 of Dir 2001/83 EG provides for an assessment report (AR) which describes the assessment of the medicinal product and states the reasons for the conclusions. The purpose of this guideline is ...

EMA: New Guideline on Development of Medicines for Paediatric Use.

The European Medicines Agency has recently published a draft guideline on pharmaceutical development of medicines for paediatric use. In January 2007 Regulation EC No 1901/2006 (the \"Paediatric ...

EMA: Reflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials.

As IVR/IWR systems are developed to facilitate overall drug management and expanded to assist with dose titration, unblinding and expiry date update, the intent of the paper is to provide guidance ...

FDA: E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure, and Format of Qualification Submissions.

The guidance describes recommendations regarding context, structure and format of regulatory submissions for qualification of genomic biomarkers (as defined in ICH E15). Qualification is a ...

HMA: Requirements on Electronic Submissions (NeeS and eCTD) and Paper Documentation for New Applications within MRP, DCP or National Procedures.

This document describes the documentation requested by each National Competent Authority for new applications for approval for Marketing Authorisation. ...

HMA: Contact Points for Advice on Mutual Recognition and Decentralised Procedures.

The list is provided to assist pharmaceutical companies identifying a contact point for advice on the Mutual Recognition or Decentralised Procedures in each Member State. The persons listed should ...

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny